KCNA3 and myeloid sarcoma: Peripheral blood mononuclear cells from North American MS patients expressed higher ShK-F6CA staining than cells from healthy individuals, which is indicative of more cell surface KV1.3 tetramers (Figure 4C2, p < 0.001).